Fair-Value Report — Tian An China Investments (0028.HK)
1. Insider Signal
Buyer: Allied Group Limited (controlling shareholder, HKEX: 0373) via a controlled corporation, with concert parties Lee Seng Huang, Lee Seng Hui, and Lee Su Hwei (Lee family, ultimate controllers via Lee and Lee Trust)
HKEX DI Filing: Allied Group Form 2, serial CS20260604E00455 | Reason Code: 1101 — On-Exchange Purchase
Trade Date: 4 June 2026 | Shares Acquired: 7,389,000 ordinary shares | Average Price: HKD 3.9999 | Total Consideration: approximately HKD 29.55 million
Holding After: Allied Group 842,996,096 shares = 57.50% (increased from 56.99% prior; +0.51 percentage points)
Signal Assessment: GENUINE open-market accumulation — PASS all gate criteria. Reason code 1101 (on-exchange) definitively rules out subscription, placing, rights issue, share scheme, or off-exchange transfer (which would be code 1103 or 1004). The Form 2 remarks box confirms standard exchange-executed acquisition. No concurrent placing, subscription, or capital-raising announcement for 0028 was identified around this date. The March 2026 Shenzhen property acquisition (a discloseable corporate transaction) is a separate event unrelated to these share purchases. The Lee family has owned and operated Tian An China since 1987 — buying HKD 29.55M of stock near the 5-year low is a substantive, committed signal, not a token transaction.
Concert party note: Allied Group is the economic buyer; the multiple Form filings (Lee Seng Huang, Lee Seng Hui, Lee Su Hwei) are reporting obligations within the concert party chain, not separate purchases. The underlying purchase is one transaction of 7,389,000 shares.
2. Verified Snapshot
Sources: StockAnalysis.com (income statement, balance sheet, dividend history) cross-referenced against HKEX announcement summaries. FY2025 = year ended 31 December 2025; results announced 20 March 2026 (ahead of HKEX 31 March deadline — no late-filing concern). All figures in HKD; majority of operations are RMB-denominated (translated). Primary HKEX filings at hkexnews.hk (stock code 0028) are the authoritative source; English aggregators used as cross-checks here. Shares outstanding stable at 1,466M since at least FY2022 — no evidence of ATM program, convertibles, or dilutive instruments.
3. Business Description
Tian An China Investments is a Hong Kong-incorporated investment holding company listed on the HKEX since 1987 — one of the earliest "China Concept Stocks" on the exchange. It is the primary vehicle through which Allied Group Limited (HKEX: 0373, controlled by the Lee family's Lee and Lee Trust at approximately 75%) conducts its mainland China property operations. Three reportable segments:
- Property Development (dominant, highly lumpy): Large-scale residential and commercial projects in mainland China, recognised on completion and handover. The flagship is The One Tian An Place, Shanghai — Phase 2C handovers drove virtually all of FY2025's HKD 10.5B revenue. Revenue is project-cycle driven: FY2021–2024 ranged from HKD 2.6B to 5.1B. In March 2026 the company acquired three additional mainland China properties for approximately RMB 676M, indicating continuing pipeline investment.
- Property Investment (stable, smaller): Holds offices, commercial, and industrial properties in mainland China and Hong Kong for rental income. Carried at HKFRS fair value; negative revaluations during China commercial property weakness contributed to the FY2024 reported loss.
- Healthcare & Other (subscale): Hospitals, eldercare, and health-related businesses in mainland China. Small revenue contributor; not yet a material driver of group earnings.
Corporate chain: Lee and Lee Trust (~75% of Allied Group) → Allied Group Limited (HKEX: 0373) → 57.5% of Tian An China Investments (HKEX: 0028). Ongoing connected transactions between Tian An China and Allied Group are covered by a renewed service agreement through 31 December 2028.
4. Financial History
| Fiscal Year | Revenue (HKD M) | Net Profit/(Loss) (HKD M) | Basic EPS (HKD) | DPS (HKD) | Note |
|---|---|---|---|---|---|
| FY2021 | 2,575 | 1,430 | 0.96 | 0.20 | Normal completion year |
| FY2022 | 5,087 | 1,529 | 1.04 | 0.25 | Elevated completions |
| FY2023 | 2,782 | 1,217 | 0.83 | 0.20 | Lower completions |
| FY2024 | 3,012 | (207) | (0.14) | 0.10 | Investment property FV losses |
| FY2025 | 10,498 | 1,768 | 1.21 | 0.20 | PEAK — Shanghai Phase 2C |
| Balance Sheet Item | FY2025 (HKD M) | FY2024 (HKD M) |
|---|---|---|
| Total Assets | 56,062 | 58,411 |
| Cash & Equivalents | 6,843 | 10,572 |
| Short-Term Debt | 2,242 | 3,368 |
| Long-Term Debt | 4,492 | 3,870 |
| Total Debt (reported) | 7,734 | 7,238 |
| Net Debt | 891 | 2,769 (net debt) |
| Total Equity (incl. minorities) | 30,382 | 28,163 |
| Minority Interest | ~1,719 | ~1,776 |
| Shareholders' Equity (ex-minorities) | ~28,663 | ~26,387 |
| Book Value / Share (HKD) | 19.55 | ~18.00 |
| Net Debt / Shareholders' Equity | 3.1% | 10.5% |
Source: StockAnalysis.com, cross-checked against HKEX announcement summaries. FY2025 total debt (HKD 7,734M) from StockAnalysis.com; note this is slightly higher than the sum of the two debt line items, likely reflecting other financial liabilities. Net debt = total debt minus cash.
5. Valuation
Methodology: Adjusted P/B (NAV Discount) — Primary
Tian An China is a mixed property developer / investment holding company with project-driven (lumpy) earnings and a balance sheet dominated by real-estate assets carried at HKFRS fair value (investment properties) or lower of cost/NRV (development inventory). Free-cash-flow DCF is inappropriate here — earnings are not recurring and the primary value is in the asset base. The standard approach is P/B relative to NAV, supplemented by normalised P/E as a cross-check.
Cost of equity (CAPM, verified via wacc.py):
| HK 10-Year Risk-Free Rate | 4.00% |
| Beta (HK property developer/holder, Damodaran) | 0.80 |
| Equity Risk Premium (China-exposed HK listed) | 6.50% |
| Country Risk Premium | 0.00% (embedded in ERP) |
| Cost of Equity (Ke) | 9.20% |
| WACC (target 90/10 equity/debt split; 5.5% pre-tax debt; 22% tax) | 8.71% |
Warranted P/B (Gordon Growth anchor):
Warranted P/B = (ROE − g) / (Ke − g)
Normalised ROE = HKD 0.70 normalised EPS ÷ HKD 19.55 BV = 3.58%
Terminal growth (g) = 2.0% (long-run nominal HKD GDP)
Ke = 9.20%
Warranted P/B = (3.58% − 2.0%) / (9.20% − 2.0%) = 1.58% / 7.20% = 0.22x
The current market multiple of 0.20x is almost exactly at the theoretical Gordon Growth fair value under a pessimistic normalised ROE of 3.6%. This is not a screaming buy on fundamentals alone — the stock is cheap, but it is priced to reflect weak earnings. The investment case is that (a) the asset base is well-covered (near-net-cash) limiting downside, (b) controlling shareholders are accumulating at this level, and (c) any recovery in project completions or China property valuations will drive ROE above 3.6%, making the current 0.20x P/B a discount rather than fair value.
Scenario Analysis: P/B (Primary)
| Scenario | Rationale | P/B Applied | Fair Value (HKD) | vs. HKD 4.00 | Weight |
|---|---|---|---|---|---|
| Bull | China property market stabilises / mild recovery; investment portfolio FV rebound; new project completions 2027+; ROE normalises to 4.5%; P/B re-rates to 0.32x | 0.32x | 6.26 | +56.5% | 25% |
| Base | Moderate headwinds continue; investment properties modestly impaired further; lumpy development earnings; ROE ~3.6%; P/B stays around theoretical warranted level 0.25x | 0.25x | 4.89 | +22.3% | 50% |
| Bear | Prolonged China downturn; substantial FV writedowns on investment portfolio; pipeline delays; ROE falls below 2%; P/B compressed to 0.15x | 0.15x | 2.93 | −26.8% | 25% |
| Probability-Weighted Fair Value | 4.74 | +18.5% | |||
Cross-Check: Normalised P/E
Normalised EPS anchor: HKD 0.70 (25% haircut to FY2021–FY2023 average EPS of HKD 0.94, reflecting ongoing China headwinds; excludes FY2024 loss year and FY2025 peak year). This is a secondary cross-check — P/E is not the right primary lens for a lumpy project-based business.
| Scenario | Normalised EPS (HKD) | P/E Applied | Fair Value (HKD) | Weight |
|---|---|---|---|---|
| Bull | 0.85 | 9x | 7.65 | 25% |
| Base | 0.70 | 7x | 4.90 | 50% |
| Bear | 0.50 | 4x | 2.00 | 25% |
| Probability-Weighted | 4.89 | |||
Both methods converge: P/B probability-weighted FV = HKD 4.74; P/E cross-check = HKD 4.89. Blended fair value: HKD 4.80 (rounded midpoint, reflecting the limited precision of either estimate given earnings lumpiness).
Reverse Read
At HKD 4.00, the market is pricing in a P/B of 0.205x. Under the Gordon Growth framework (Ke = 9.20%, g = 2.0%), this implies a perpetual normalised ROE of just 3.6% — or equivalently, normalised EPS of only approximately HKD 0.57/share at 7x P/E, which is a 40% haircut to the FY2021–2023 historical average of HKD 0.94. The implied pessimism is not irrational given China property headwinds, but it leaves essentially no credit for any positive outcome: new completions, China policy support, or asset-value stabilisation. The near-net-cash balance sheet (net debt only HKD 891M on HKD 56B total assets; net debt/equity = 3.1%) makes an outright stress/distress scenario unlikely. The stock is priced for prolonged malaise, not catastrophe — which is why the controlling shareholder is buying.
Peer Comparison
Peer figures are approximate estimates from secondary sources (StockAnalysis.com, Bloomberg summaries) as of approximately June 2026. Individual figures not independently verified against primary HKEX filings for each peer. Use for directional comparison only.
| Ticker | Company | Mkt Cap (HKD B, est.) | P/B (est.) | Net Debt / Equity | Div Yield (est.) | Profile |
|---|---|---|---|---|---|---|
| 0028.HK | Tian An China | 5.9 | 0.20x | 3.1% | 5.0% | China dev + HK/China investment |
| 0101.HK | Hang Lung Properties | ~22 | ~0.22x | ~50% | ~5.5% | China commercial RE investor |
| 0083.HK | Sino Land | ~32 | ~0.33x | Net cash | ~4.5% | HK-focused developer/investor |
| 0683.HK | Kerry Properties | ~12 | ~0.22x | ~40% | ~4.0% | HK/China mixed dev+investment |
| 0041.HK | Great Eagle Holdings | ~8 | ~0.17x | ~20% | ~3.0% | HK investment holding (hotels+RE) |
| 0004.HK | Wharf Holdings | ~37 | ~0.28x | ~30% | ~4.0% | HK/China premium retail RE |
| Peer Median (excl. target) | ~0.22x | ~35% | ~4.3% | |||
| Target vs. Median | -9% discount | -32 ppts (better) | +70bps | |||
Tian An China trades at a 9% discount to the peer median P/B of approximately 0.22x, despite having the lowest leverage in the peer group by a wide margin (3.1% net debt/equity vs. peer median of approximately 35%). A near-net-cash balance sheet typically warrants a premium to leveraged peers, not a discount — especially in a risk-off property environment where credit stress is a concern for the higher-debt names. The leverage-adjusted gap confirms Tian An China is the cheapest name in this peer set on a risk-adjusted basis.
6. Conclusion
Rating: Speculative Buy | Base Fair Value: HKD 4.80 | Current Price: HKD 4.00 (8 June 2026) | Potential Upside: ~20% (base), ~57% (bull)
Three things are working simultaneously here, and they rarely align:
- Genuine insider buying. The controlling family (36 years of ownership) just paid HKD 29.55M from their own pocket at the near-5-year low. This is reason code 1101 (on-exchange), not a corporate subscription or share scheme. They see more value than the market is pricing.
- Extreme valuation discount. P/B of 0.20x is at the low end of even the distressed HK property peer group — and Tian An China has the cleanest balance sheet in the set (3.1% net debt/equity). The warranted P/B under base earnings assumptions is 0.22x, meaning the stock is slightly cheap even before any recovery scenario.
- Earnings cycle inflection. The company swung from a HKD 207M loss in FY2024 to HKD 1.77B profit in FY2025 — an earnings recovery confirmed in the audited full-year results (published March 2026, on time). The 5.0% dividend yield demonstrates management willingness to distribute.
The "Speculative" rating (rather than "Moderate Buy") is warranted because: FY2026 earnings are genuinely uncertain pending next project-completion announcements; China property market conditions remain structurally challenged; and the low free float (~42.5%) means the stock may not re-rate without a specific positive catalyst. This is not a quality compounder — it is a deeply discounted property holding company with a supportive insider signal and a protective balance sheet. Sizing should be modest relative to a conviction portfolio.
7. Key Risks
- China property market: Continued residential or commercial price weakness could impair both development margins and investment property HKFRS fair values, compressing book value below HKD 19.55 and widening the discount. The FY2024 loss year shows this is not hypothetical.
- Revenue/earnings lumpiness (FY2026 cliff): FY2025's HKD 10.5B revenue was a one-time Phase 2C completion event. FY2026 revenue and profit will depend on what phases/projects reach handover. If no major completions occur, EPS could fall to HKD 0.30–0.50, depressing sentiment further.
- Connected transactions / governance: Ongoing service arrangements with Allied Group (parent, 57.5% shareholder) and the Lee family's dual role as owners of both entities create structural related-party risk. Minority shareholders have limited recourse given the concentration of control.
- Investment property revaluation: Non-cash fair-value losses on the investment property portfolio (offices, commercial, industrial) directly hit the income statement under HKFRS. A further downturn could produce a reported loss in FY2026 even if the development business is active.
- RMB/HKD currency risk: The majority of assets and earnings are RMB-denominated; a weaker RMB would reduce HKD-equivalent book value and earnings (though the HKD peg to USD limits the HKD/USD effect).
- Low free float / liquidity: Approximately 42.5% free float limits institutional participation. Daily trading volume may be thin; large buy or sell orders can move the price materially.
- Healthcare segment capital allocation: The healthcare business is still subscale and its capital requirements are unclear; continued investment without returns could weigh on group ROE.
8. Sources
- HKEX DION — Allied Group Form 2 (CS20260604E00455): on-exchange purchase, 7,389,000 shares, 4 June 2026. Primary signal source.
- HKEX DION — Lee Seng Huang Form 1 (IS20260604E00467); Lee Seng Hui Form 3A (DA20260604E00448); Lee Su Hwei Form 1 (IS20260604E00472). Concert party filings confirming single underlying trade.
- HKEX filings search (hkexnews.hk, stock code 0028) — FY2025 annual results announced 20 March 2026; FY2024 results announced 28 March 2025. Filing dates confirmed; no late-filing or suspension concern.
- StockAnalysis.com (0028.HK) — income statement FY2021–FY2025, balance sheet FY2024–FY2025, dividend history. English aggregator; cross-checked against HKEX.
- Google Finance (0028:HKG) — price HKD 4.00 as of 8 June 2026 (intraday). Price source.
- TipRanks, Simply Wall St — summaries of HKEX H1 2025 interim results (22 August 2025), profit alert, dividend ex-date (27 April 2026), payment date (15 May 2026), 2026 AGM (20 May 2026), March 2026 Shenzhen property acquisition announcement. Timeline verification.
- Tian An China company website (tiananchina.com) — business description and segment overview.
- Allied Group website (alliedgroup.com.hk) — ownership structure (Lee family / Lee and Lee Trust).
- Damodaran NYU Stern (pages.stern.nyu.edu/~adamodar/) — implied ERP for China/HK (approximately 6.5%); real estate (non-REIT) industry beta (approximately 0.8). WACC inputs.
- WACC computed via wacc.py (scripts/wacc.py): Ke = 9.20%, WACC = 8.71% (config: Rf 4.0%, beta 0.80, ERP 6.5%, cost of debt 5.5% pre-tax, 22% tax, 90/10 equity/debt target).
No redactions applied.
Published via wiis. Originals are encrypted at rest; this page reflects the redacted version. report abuse.
Discussion
No comments yet.